You are here

P&T News

February 20

Follow-up data published from nine-year-old study
Treatments show similar efficacy, safety, and tolerability profiles
“Sickest of the sick” lead health care spending
State-run databases track prescribing of controlled substances

February 17

Drug surged in summer of 2016, causing hundreds of overdose deaths
Researchers utilize gene activity signatures to identify candidates
Annualized relapse rate reduced compared with interferon beta-1a
Committee sees “virtually no chance” of a positive effect

February 16

New rule seeks to prevent enrollees from “gaming the system”
Is common steroid worth the price?
Siliq binds to pro-inflammatory protein
Inhalation spray now approved for age 6 and older

February 15

STAT investigation finds many promises but few results
Data show noninferiority to darunavir
Insurance coverage hinges on solid efficacy data
Company’s move may herald things to come

Pages